ALLISON GATLIN / Investor’s Business Daily – Business
Highly Rated Medtech Tops Quarterly Earnings Forecast, But Sales Light – Resmed earnings came in ahead of views at $1 per share, on an adjusted basis, but $651.1 million in sales were light. Resmed stock dipped late Thursday. The post Highly Rated Medtech Tops Quarterly Earnings Forecast, But Sales Light appeared first on Investors Business Daily. Resmed (RMD) on Thursday reported …
